Navigation Links
Houston Heart Surgeon Elected Vice President of Guatemala
Date:11/5/2007

GUATEMALA CITY, Guatemala, Nov. 5 /PRNewswire/ -- World-renowned heart surgeon Dr. Rafael Espada has made history by becoming the first physician elected Vice President of Guatemala. President-elect Alvaro Colom, with Dr. Espada as his running mate, won yesterday's presidential run-off after earning more than 52.8 percent of the country's votes. The two will take office January 14, 2008.

A native of Guatemala, Dr. Espada has practiced for more than 30 years as a heart surgeon in Houston. He most recently was Deputy Chief of Cardiothoracic Surgery at the Methodist DeBakey Heart Center at The Methodist Hospital.

Dr. Espada's decision to return to Guatemala stems from his continued relationship with the country during his time in the United States. While in Houston, he established Guatemala's first cardiac hospital, Unidad Cardiovascular, which has become the premier heart hospital in Central America.

He also has traveled to Guatemala nearly every month over the last two decades to perform free surgeries for numerous Guatemalan citizens. He routinely has advised Guatemalan officials on a variety of healthcare and economic issues, including successfully mediating a strike between the government and the country's medical professionals.

Dr. Espada says his position of vice president will allow him to build on the economic development and healthcare improvements he has been working on during his time in the United States.

"A great number of Guatemalans are living in poverty, and a great number are sick and dying," says Dr. Espada. "The two problems are not mutually exclusive, and solutions go hand-in-hand. If we can create jobs and spur the economy, more people will be able to afford healthcare."

Dr. Espada's economic development plan involves creating a strong, diversified economy by creating jobs within the country and attracting more international business and investors.

"A safer, better educated country is the key to Gua
'/>"/>

SOURCE Dr. Rafael Espada
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
2. Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston
3. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
4. Houston Northwest Medical Centers Patient Outcomes Superior
5. Cohen Design Centers Sponsor the AIDS Walks in Los Angeles, Houston, Fort Lauderdale and New York
6. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
7. Houston Employers Hear New Research That Supports the Case for Retail Clinics
8. New St. Lukes Medical Clinic Selects Award-Winning globalcentara Provider(SM) by Houstons Global Healthcare Alliance
9. Drug for cluster headaches may cause heart problems
10. Use of certain lipid measures not more effective in predicting coronary heart disease
11. Restricting Blood Flow May Help Heart Bypass Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... have made a discovery that turns 160 years of ... material long known to be essential for the fast ... is not as ubiquitous as thought, according to a ... Harvard Stem Cell Institute (HSCI) and the University,s Department ... Professor Jeff Lichtman, of Harvard,s Department of Molecular and ...
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... of chronic inflammation in non-cancerous prostate tissue may have ... than those with no inflammation, according to results of ... Hopkins Kimmel Cancer Center. , The link between persistent ... so-called high-grade prostate cancer those with a Gleason ... of the most aggressive and rapidly growing prostate cancers. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2
... IRVING, Texas, Dec. 13 Allarae Healthcare,Inc. (Pink Sheets: ... with Intellect, Inc. to sell their entire product line ... broad range,of personal health testing kits, several already FDA ... kits are ready for market but have,not yet been ...
... as Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA ... the completion of a new network,infrastructure to support a ... and Thurrock University Hospitals, part,of the NHS Foundation Trust ...
... shouldn,t feel like,getting your teeth drilled, according to Mirabai ... industry. For anyone who,s vowed to,start exercising in the ... help them get going. Recently released on DVD, the ... exercise,going at their own pace, so they,re more likely ...
... and females in order to alleviate back pressure from ... spearheaded at The University of Texas at Austin. , ... in the Dec. 13 issue of Nature. , The ... million years ago, in the early human ancestor Australopithecus. ...
... to allowing us to see, the mammalian eye also detects ... of this is the timing of the sleep/wake cycle, which ... pacemaker in the hypothalamus. , In a study published ... two totally blind humans whose non-visual responses to light remain ...
... 13 PARI,s eFlow, an advanced,electronic nebulizer, was ... Phase I human clinical trial. Results of the ... Annual Drug Delivery to the Lungs meeting held,in ... developed as a,treatment for respiratory syncytial virus (RSV) ...
Cached Medicine News:Health News:Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc. 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2Health News:Adapting to pregnancy played key role in human evolution, study shows 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3Health News:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study 2
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle. Designated most popular model or size....
8 mm curved blade. Cutting edge on inside of curve. Flat handle....
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size....
Medicine Products: